Patanjali Ayurved's research, published in the Journal of Inflammation Research, reveals promising results for their Ayurvedic treatment of psoriasis using Psorogrit tablets and Divya Taila ...

Company increases capabilities across pet chews, capsules, tablets, and gummies to meet growing market demand Fountain Valley ...

SAN CARLOS, Calif., June 11, 2025--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has ...

The FDA has approved a tablet form of Livmarli (maralixibat) for cholestatic pruritus in patients with Alagille syndrome and progressive familial intrahepatic cholestasis.

Formulation The formulation of MounjaSlim is meticulously designed, blending traditional herbal remedies with modern nutritional science.

BeOne Medicines Ltd., a global oncology company, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency issued a positive opinion recommending ...

Maintaining optimal health has become a challenge for many in today’s fast-paced world. As individuals increasingly seek natural solutions to boost their well-being, dietary supplements have gained ...

Patanjali Ayurved's research, published in the Journal of Inflammation Research, reveals promising results for their Ayurvedic treatment of psoriasis using Psorogrit tablets and Divya Taila.

“The CHMP’s positive opinion of our new tablet formulation of BRUKINSA is an important step toward bringing this thoughtful, patient-centered innovation to people facing certain B-cell cancers ...